Download PDF
Dtsch Med Wochenschr 2021; 146(04): 266-278
DOI: 10.1055/a-1270-8878
CME-Fortbildung

Akute diabetische Stoffwechselentgleisungen

Acute metabolic complications in diabetes
Melina Mertens   *
,
Laura Dauben   *
,
Michael Roden
,
Karsten Müssig
› Further Information
Also available at
    Permissions and Reprints

Patienten mit Diabetes mellitus weisen eine erhöhte Morbidität und Letalität infolge der mikro- und makrovaskulären Komplikationen auf. Zudem kann es bei Erstmanifestation, aber auch während des weiteren Krankheitsverlaufs, zu lebensbedrohlichen Stoffwechselentgleisungen kommen. Treten diabetesbedingte Notfälle auf, ist eine schnelle Diagnose und Therapieeinleitung unerlässlich.

Abstract

Over time, diabetes patients are at increased risk for microvascular and macrovascular complications leading to increased morbidity and mortality compared to metabolically healthy people. In addition, acute life-threatening metabolic derangements at first manifestation as well as during the course of the disease may occur, comprising diabetic ketoacidosis, hyperosmolar hyperglycaemic state and hypoglycaemia. Diabetes-related emergencies require fast diagnosis and early treatment initiation as well as close monitoring of vital signs and laboratory parameters. The present article gives an overview on the acute metabolic complications in diabetes, focussing on diagnostic work-up and treatment goals.

Schlüsselwörter

Hypoglykämie - diabetische Ketoazidose - hyperglykämisches - hyperosmolares Koma - Notfall - Diabetes mellitus

Key words

hypoglycaemia - diabetic ketoacidosis - hyperglycaemic hyperosmolar state - emergency - diabetes mellitus

* Die Autorinnen haben zu gleichen Teilen zu dem Manuskript beigetragen.




Publication History

Article published online:
16 February 2021

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Seaquist ER, Anderson J, Childs B. et al Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013; 36: 1384-1395 . doi:10.2337/dc12-2480
    CrossrefPubMedGoogle Scholar
  • 2 Khunti K, Alsifri S, Aronson R. et al Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab 2016; 18: 907-915 . doi:10.1111/dom.12689
    CrossrefPubMedGoogle Scholar
  • 3 Deutsche Diabetes Gesellschaft (DDG). S3-Leitlinie Therapie des Typ-1-Diabetes. 2. Auflage – AWMF-Registernummer: 057-013. Diabetologie und Stoffwechsel 2018; 13: 1-58
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Elliott L, Fidler C, Ditchfield A. et al Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes. Diabetes Ther 2016; 7: 45-60 . doi:10.1007/s13300-016-0157-z
    CrossrefPubMedGoogle Scholar
  • 5 Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008; 57: 3169-3176 . doi:10.2337/db08-1084
    CrossrefPubMedGoogle Scholar
  • 6 Müssig K, Schleicher ED, Häring HU. et al Satisfactory outcome after severe ethanol-induced lactic acidosis and hypoglycemia. J Emerg Med 2008; 34: 337-338 . doi:10.1016/j. jemermed.2007.04.028
    CrossrefPubMedGoogle Scholar
  • 7 Heni M, Schott S, Horger M. et al Seltene Ursache für eine Hypoglykämie bei einem Patienten mit Typ-2-Diabetes mellitus. Dtsch Med Wochenschr 2009; F2 (Suppl. Falldatenbank: 134 . doi:10.1055/s-0028-1082826
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Schwarz F, Roden M, Fritsche A. et al Seltene Ursache rezidivierender Hypoglykämien bei Diabetes mellitus Typ 1. Dtsch Med Wochenschr 2013; 138: 1470 . doi:10.1055/s-0033-1343305
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Gördes L, Achenbach P, Roden M. et al Eine seltene Ursache für eine hyperinsulinämische Hypoglykämie. Diabetologie und Stoffwechsel 2017; 12: 184-185 . doi:10.1055/s-0043-104820
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Kalscheuer H, Serfling G, Schmid S. et al Diabetologische Notfälle. Hypoglykämie, ketoazidotisches und hyperglykämisches Koma. Internist 2017; 58: 1020-1028 . doi:10.1007/s00108-017-0317-x
    CrossrefPubMedGoogle Scholar
  • 11 Ratter JM, Rooijackers HMM, Tack CJ. et al Proinflammatory Effects of Hypoglycemia in Humans with or without Diabetes. Diabetes 2017; 66: 1052-1061 . doi:10.2337/db16-1091
    CrossrefPubMedGoogle Scholar
  • 12 International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: A joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2017; 40: 155-157 . doi:10.2337/dc16-2215
    CrossrefPubMedGoogle Scholar
  • 13 Canadian Diabetes Association. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2013; 37: S1-S216
    CrossrefPubMedGoogle Scholar
  • 14 Frier BM, Schernthaner G, Heller SR. Hypoglycemia and Cardiovascular Risks. Diabetes Care 2011; 34: S132-S137 . doi:10.2337/dc11-s220
    CrossrefPubMedGoogle Scholar
  • 15 American Diabetes Association (ADA). Standards of Medical Care in Diabetes – 2017. Diabetes Care 2019; 40: S1-S193
    PubMedGoogle Scholar
  • 16 Fayfman M, Pasquel FJ, Umpierrez GE. Management of hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am 2017; 101: 587-606 . doi:10.1016/j.mcna.2016.12.011
    CrossrefPubMedGoogle Scholar
  • 17 Kitabchi AE, Umpierrez GE, Miles JM. et al Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009; 32: 1335-1343 . doi:10.2337/dc09-9032
    CrossrefPubMedGoogle Scholar
  • 18 Donnan JR, Grandy CA, Chibrikov E. et al Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis. BMJ Open 2019; 9: e022577 . doi:10.1136/bmjopen-2018-022577
    CrossrefPubMedGoogle Scholar
  • 19 Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism 2016; 65: 507-521 . doi:10.1016/j.metabol. 2015.12.007
    CrossrefPubMedGoogle Scholar
  • 20 Schumann C, Faust M. Diabetologische Notfälle: Ketoazidose und hyperglykämes Koma. Dtsch Med Wochenschr 2018; 143: 384-391 . doi:10.1055/s-0043-114493
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Bull SV, Douglas IS, Foster M. et al Mandatory protocol for treating adult patients with diabetic ketoacidosis decreases intensive care unit and hospital lengths of stay: results of a nonrandomized trial. Crit Care Med 2007; 35: 41-46 . doi:10.1097/01.CCM.0000249825.18677.D2
    CrossrefPubMedGoogle Scholar
  • 22 Kaser S, Sourij H, Clodi M. et al Therapie der akuten diabetischen Stoffwechselentgleisungen bei Erwachsenen (Update 2019). Wien Klin Wochenschr 2019; 131: S196-S199 . doi:10.1007/s00508-018-1423-z
    CrossrefPubMedGoogle Scholar
  • 23 Nyenwe EA, Kitabchi AE. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract 2011; 94: 340-351 [Epub 2011 Oct 5]. doi:10.1016/j.diabres.2011.09.012
    CrossrefPubMedGoogle Scholar
  • 24 Bradford AL, Crider CC, Xu X. et al Predictors of Recurrent Hospital Admission for Patients Presenting With Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. J Clin Med Res 2017; 9: 35-39 . doi:10.14740/jocmr2792w
    CrossrefPubMedGoogle Scholar
  • 25 Inakova J, Thompson-Leduc P, Kirson NY. et al Efficacy and safety of procalcitonin guidance in patients with suspected or confirmed sepsis: a systematic review and meta-analysis. Crit Care Med 2018; 46: 691-698 . doi:10.1097/CCM.0000000000002928
    CrossrefPubMedGoogle Scholar